Ranbaxy moves production in FDA workaround; Chinese company, managers fined for substandard drugs;

> Due to issues still pending with the FDA, Ranbaxy has shifted production of its Lipitor and Aricept generics out of its Paonta Sahib and Dewas plants in India to a New Jersey facility. Article

> Simcere-controlled Jiangsu Yanshen Biological Technology has been found liable for producing substandard human-use rabies vaccine and fined $4.5 million, in addition to individual penalties imposed on members of the management team. Simcere release

> GSK has short-listed Barnard Castle, in County Durham, UK, for its new biopharmaceutical plant. Story

> The five major vaccines companies--Sanofi Pasteur, Merck, GSK, Pfizer, and Novartis--comprise an oligopoly formed by high manufacturing and distribution costs insurmountable by smaller players. Report

> Four laboratories, funded in large part by Teva and a development foundation, mark Israel's first for research, development and teaching of pharmaceutical engineering. Article

> Eli Lilly's ImClone manufacturing plant in Branchburg, NJ, home to Erbitux production and 141 jobs, will close this month. Article

> Standards devote scan attention to color management, despite an emphasis on printing industry quality for packaging contamination control. Story

> Adamis Pharma and Beximco Pharma will team to introduce four generic respiratory drug formulations in the U.S. Item

> J&J says it will continue with its acquisition of Crucell but reserves the option to renegotiate the $2.27 billion price if problems at the Dutch biotechnology company's manufacturing plant in South Korea prove worse than anticipated. Article

> Animal drugmaker Bimeda will pay a $7,000 fine and spend $59,000 on environmental upgrades after Minnesota cited the company for hazardous waste violations. Article

> Datex is offering IT services in conjunction with its FootPrint WMS software. Datex release

> Russian drug distributor Protek is implementing an IBM Power7 system for its data processing center. IBM release

Suggested Articles

South Korea’s Celltrion, which has a massive biologics site in Songdo, has decided it is time to build some operations in China.

WuXi Biologics is taking control of a Bayer plant in Germany and agreed it could serve as a backup facility for supply of hemophilia drug Kovaltry.

A Chinese OTC drugmaker gets the distinction of ringing in the new year as the first company to be slapped with an FDA warning letter.